Inventor · disambiguated record
Guru V. Betageri
Also filed as: BETAGERI GURU · BETAGERI GURU V
14 granted patents·14 pending applications·84 citations·filing 2000–2021
91Inventor score
Files withUNIV WESTERN HEALTH SCIENCES13BETAGERI GURU V5TESORX PHARMA LLC3ENZREL INC1ORADEL MEDICAL LTD1
Top patents by PatentIndex Score
28 records- 0187US6761901B1Liposome drug deliveryENZREL INC·Filed 2000·Granted Jul 13, 2004·25 cites·29 claims
- 0284US9844557B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2016·Granted Dec 19, 2017·4 cites·17 claims
- 0383US9445995B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2015·Granted Sep 20, 2016·4 cites·11 claims
- 0481US7387791B2Liposome drug deliveryORADEL MEDICAL LTD·Filed 2004·Granted Jun 17, 2008·14 cites·46 claims
- 0581US6759058B1Enteric-coated proliposomal formulations for poorly water soluble drugsWESTERN CT FOR DRUG DEV COLLEG·Filed 2001·Granted Jul 6, 2004·14 cites·10 claims
- 0680US8957053B2Proliposomal testosterone formulationsBETAGERI GURU V·Filed 2014·Granted Feb 17, 2015·4 cites·20 claims
- 0779US9623033B2Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2016·Granted Apr 18, 2017·2 cites·13 claims
- 0879US6849269B2Proliposomal drug delivery systemWESTERN UNIVERSITY OF HEALTH S·Filed 2002·Granted Feb 1, 2005·12 cites·25 claims
- 0972US9566238B2Formulation of PEGylated-liposome encapsulated glycopeptide antibioticsPUMERANTZ ANDREW·Filed 2011·Granted Feb 14, 2017·2 cites·19 claims
- 1070US9492387B2Ternary mixture formulationsBETAGERI GURU V·Filed 2011·Granted Nov 15, 2016·1 cites·6 claims
- 1170US8889180B2Coated drug delivery formulationsBETAGERI GURU V·Filed 2011·Granted Nov 18, 2014·1 cites·20 claims
- 1263US2005031687A1Enteric-coated proliposomal formulations for poorly water soluble drugsFiled 2004·Application pending·0 cites
- 1362US8658202B2Coated drug delivery formulationsBETAGERI GURU V·Filed 2004·Granted Feb 25, 2014·1 cites·26 claims
- 1460US2009123530A1Liposome Drug DeliveryBETAGERI GURU V·Filed 2008·Application pending·0 cites
- 1559US2019133946A1Novel formulation of pegylated-liposome encapsulated glycopeptide antibioticsUNIV WESTERN HEALTH SCIENCES·Filed 2018·Application pending·0 cites
- 1659US2018303850A1Proliposomal testosterone formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 1757US2015140092A1Coated drug delivery formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2014·Application pending·0 cites
- 1856US2010143481A1Method of preparing solid dosage forms of multi-phasic pharmaceutical compositionsSHENOY DINESH·Filed 2007·Application pending·0 cites
- 1955US2021267896A1Formulations for treating bladder cancerUNIV WESTERN HEALTH SCIENCES·Filed 2021·Application pending·0 cites
- 2054US11229602B2Formulations for treating bladder cancerUNIV WESTERN HEALTH SCIENCES·Filed 2017·Granted Jan 25, 2022·0 cites·16 claims
- 2154US2018311166A1Ternary mixture formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 2253US9808426B2Ternary mixture formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2016·Granted Nov 7, 2017·0 cites·6 claims
- 2351US2017231912A1Novel formulation of pegylated-liposome encapsulated glycopeptide antibioticsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 2442US2022265679A1Proliposomal testosterone undecanoate formulationsTESORX PHARMA LLC·Filed 2020·Application pending·0 cites
- 2536US2020170993A1Liposomal paclitaxel formulation for treating bladder cancerTESORX PHARMA LLC·Filed 2018·Application pending·0 cites
- 2635US2022000777A1Liposomal enhanced intra-peritoneal chemotherapyTESORX PHARMA LLC·Filed 2019·Application pending·0 cites
- 2732US2019343763A1Methods of treating upper tract urothelial carcinomasUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
- 2832US2019248830A1Proliposomal testosterone undecanoate formulationsUNIV WESTERN HEALTH SCIENCES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guru V. Betageri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →